News | July 19, 2023
PrecisionLife identifies first detailed genetic risk factors for long COVID
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
Subscribe To Our Newsletter & Stay Updated
